Bicycle Signs US$1.7 B Immuno-oncology Collaboration with Genentech
By Michelle Liu
Pharma Deals Review: Vol 2020 Issue 3 (Table of Contents)
Published: 5 Mar-2020
DOI: 10.3833/pdr.v2020.i3.2518 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to extend its leadership in oncology, Genentech has partnered with Bicycle Therapeutics to discover, develop and commercialise immuno-oncology therapies based on the latter’s bicyclic peptide (Bicycle®) technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS